Marie Kosco‐Vilbois

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD”.

Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD

Neurobiology of Disease(2023)10.1016/j.nbd.2023.106050

N/A

0DataRank · unranked

35 citations

Elodie Chevalier, Mickaël Audrain, Christopher Dumayne, Tamar Ziehm, Roger Moser +21 more

The case for regulatory approval of amyloid‐lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence

Alzheimer s & Dementia(2024)10.1002/alz.14342

N/A

0DataRank · unranked

29 citations

Randall J. Bateman, Damian C. Crowther, Jeff Cummings, John Dwyer, Takeshi Iwatsubo +7 more

Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS/FTD

Acta Neuropathologica Communications(2024)10.1186/s40478-024-01867-z

N/A

0DataRank · unranked

8 citations

Mickaël Audrain, Monisha Ratnam, Romain Ollier, Aline Fuchs, Kasia Piorkowska +5 more

Development of [18F]ACI-19626 as a first-in-class brain PET tracer for imaging TDP-43 pathology

Nature Communications(2025)10.1038/s41467-025-64540-6

N/A

0DataRank · unranked

14 citations

Elodie Chevalier, Nicolas Dreyfus, Dorian Charmey, Tania Melly, Jacqueline Kocher +21 more